The drug fingolimod (FTY720), which agonizes the S1P receptor, prevents autoimmune lymphocytes from moving from the lymphoid organs into the central nervous system.
Lek fingolimod (FTY720), koji je antagonist S1P receptora, sprečava autoimune limfocite da pređu iz limfnih organa u centralni nervni sistem.